OTHER NCT02193061.

Trial name or title	"Randomized, Controlled Single‐blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti‐rotavirus Prevention Programs"
Methods	Randomized, controlled, single‐blind
Participants	Number: 1498 (target) Description: healthy infants 6 ‐ 10 weeks old
Interventions	1. 1 dose RV1 2. 1 dose RV5 3. 1 dose RV1 + 2 doses RV5 4. 1 dose RV5 + 2 doses RV1 5. 2 doses RV5 + 1 dose RV1 6. 1 dose RV5 + 1 dose RV1 + 1 dose RV5 7. 1 dose RV1 + 1 dose RV5 + 1 dose RV1
Outcomes	1. Temperature 2. Evacuations
Starting date	November 2013 Completion: November 2017
Contact information	Mercedes Macias Parra, MSc, National Institute of Pediatrics, Mexico
Notes	Location: Mexico Registration number: NCT02193061 Source of funding: National Institute of Pediatrics, Mexico; Centro Nacional para la Salud de la Infancia y la Adolescencia; Merck Sharp & Dohme Corp.